Circle Pharma, Inc. — Form D/A

Circle Pharma, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2025-01-10. The offering totals $117.4M, of which $92.4M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
David J EarpDirectorSOUTH SAN FRANCISCO, CA
James H EvangelistaDirectorSOUTH SAN FRANCISCO, CA
Matthew P JacobsonDirectorSOUTH SAN FRANCISCO, CA
John JoseyDirectorSOUTH SAN FRANCISCO, CA
Stephen H KelseyDirectorSOUTH SAN FRANCISCO, CA
Walter H MoosDirectorSOUTH SAN FRANCISCO, CA
Thilo H SchroederDirectorSOUTH SAN FRANCISCO, CA
David J EarpExecutive OfficerSOUTH SAN FRANCISCO, CA
Paul H ParkExecutive OfficerSOUTH SAN FRANCISCO, CA
Peter SvennilsonDirectorSouth San Francisco, CA
Elton SatuskyExecutive OfficerPalo Alto, CA
James EvangelistaDirectorSouth San Francisco, CA
Thilo SchroederDirectorGrand Duchy of Luxembourg, N4
Matthew JacobsonDirectorSouth San Francisco, CA
David EarpDirectorSouth San Francisco, CA
David EarpExecutive OfficerSouth San Francisco, CA
Walter MoosDirectorSouth San Francisco, CA
Elton J SatuskyExecutive OfficerPalo Alto, CA
John P JoseyDirectorSouth San Francisco, CA
Thilo P SchroederDirectorSouth San Francisco, CA
Peter P SvennilsonDirectorSouth San Francisco, CA
Cayla J McEwenExecutive OfficerSouth San Francisco, CA
Walter P MoosDirectorSouth San Francisco, CA
Scott R LokeyDirectorSan Francisco, CA
Douglas R CrawfordDirectorSan Francisco, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2024-08-29D/A$117.4M$63.2M
2024-07-03D$117.4M$54.2M
2022-03-22D/A$66.3M$66.3M
2021-06-29D$66.3M$35.7M
2020-03-23D$45.0M$15.0M
2016-09-09D$6.0M$3.8M

More